SGK1 and melanoma: Activation of other signaling pathways that contribute to melanoma development and are downstream of the PI3K/PDK axis, including glucocorticoid-induced protein kinase (SGK) isoforms, glycogen synthase kinase 3 (GSK3), and Jun N-terminal kinase (JNK), cannot be excluded and are under investigation.